BACKGROUND: Primary @entity1119 is characterized by excessive sweating beyond physiological needs. It is a common disease (incidence 2.8%) that causes intense discomfort for @entity1 . In the last decade, advantages of Single-Incision Thoracoscopic Sympathectomy have become clear, particularly in decreasing morbidity of sympathectomy. @entity1 AND METHODS: From January 2010 to December 2012, 39 @entity1 (29 females and 10 males) with primary @entity1119 were treated by thoracoscopic sympathectomy. The age ranged from 18 to 40 years with a mean of 26.28 years. We used single incision thoracoscopic electrocoagulation through 10 mm incision for thoracic sympathetic chain (T2-T4). RESULTS: The mean follow-up was 23.6    14.2 months (range = 4-24 months). A total of 97.42% of @entity1 were satisfied with the results. A total of 72.5% of @entity1 had cure, one @entity1 (2.5%) and another @entity1 (2.5%) presented with recurrent axillary @entity1119 . The morbidity was 10.2% with no mortality. Percentage of @entity3190 and @entity8810 were 5.1% (p = .353) and 2.5% (p = .552), respectively. The result of sympathectomy in @entity1 with both @entity1119 was significantly better (17, 43.58%) compared to palmar type (14, 35.89%) or axillary type (7, 17.94%). CONCLUSION: Thoracoscopic sympathectomy is a simple, safe, and cost-effective therapy with good results and low complications.

Single incision thoracoscopic sympathectomy for XXXX .

@entity1 :: ('9606', 'Species') :: ['patients', 'patient', 'PATIENTS'] @entity8810 :: ('MESH:D013547', 'Disease') :: ['gustatory sweating'] @entity1119 :: ('MESH:D006945', 'Disease') :: ['palmar or axillary hyperhidrosis', 'hyperhidrosis', 'palmar and axillary hyperhidrosis'] @entity3190 :: ('MESH:D006946', 'Disease') :: ['compensatory sweating']
@entity1119 :: (MESH:D006945,Disease) :: ['palmar and axillary hyperhidrosis']
